arbekacin and Atypical Mycobacterial Infection, Disseminated

arbekacin has been researched along with Atypical Mycobacterial Infection, Disseminated in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arai, Y; Fujimoto, Y; Handoh, T; Ihara, H; Kurokawa, K; Miida, T; Misawa, S; Naito, T; Nakamura, A; Ochi, Y; Okabe, T; Shibayama, K; Sumiyoshi, I; Tabe, Y; Takahashi, K; Takei, S; Togo, S; Watanabe, J1
Hattori, T; Kazato, Y; Mori, R; Shimada, H; Yamamoto, A; Yuzawa, M1

Other Studies

2 other study(ies) available for arbekacin and Atypical Mycobacterial Infection, Disseminated

ArticleYear
The synergetic effect of sitafloxacin-arbekacin combination in the Mycobacterium abscessus species.
    Scientific reports, 2023, 02-04, Volume: 13, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous

2023
Mycobacterium abscessus corneal ulcer following sutured clear corneal cataract incision.
    Japanese journal of ophthalmology, 2010, Volume: 54, Issue:5

    Topics: Anti-Infective Agents; Cataract Extraction; Cornea; Corneal Ulcer; Dibekacin; DNA, Bacterial; Eye Infections, Bacterial; Female; Humans; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Surgical Wound Infection; Suture Techniques

2010